Clicky

Bukwang Pharm(003000)

Description: Bukwang Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea and internationally. It manufactures oral solid dosage forms, injections, oral solutions, external-use solutions, and ointments. The company offers products in various therapeutic areas, including liver disease treatments, such as Levovir and Legalon; diabetic complication products comprising Dexid and Thioctacid; CNS disorder drugs consisting of Lonasen, Ixel, and Orfil; and respiratory disease treatments, which comprise Azeptin and Asima. It also provides OTC products; toothpastes, and hair and skin care goods; and nutritional supplements. In addition, the company offers products for antihistamines, hepatitis and gastrointestinal, sedative and antidote, anti-cancer, thyroid and osteoporosis, diabetes, obstetrics, urinogenital, cardiovascular, dermatology, obesity, pain relief, and muscle relaxant. Further, it provides products for bruises, skin and mucous membrane, rhinitis, cold symptoms, cough, phlegm and asthma, rheumatoid arthritis, osteoarthritis, pain caused by cold and fever, dysmenorrhea, NSAIDs, inflammation, joint inflammation, tinea pedis, infected wounds, dermatitis, antivirals-herpes, eczema, diarrhea, dyspepsia, sense of distension, anti-histamine, anti-ulcer, constipation, anemia, pregnant multivitamins, candidiasis, athlete's foot, onychomycosis, stomatitis, pimple, acne, physical fatigue, neuralgia, myalgia, and arthralgia. Additionally, the company offers medicines for period of lactation, rickets, night blindness, varicose vein, and sputum; and quasi drugs and medical devices, as well as health functional food. It also develops anti-diabetes compound with Melior Pharmaceuticals; and anti-cancer drugs with LSK BioPartners, as well as cell therapies using adult stem cells, as well as holds a license for a novel candidate to treat movement disorder in Parkinson's disease patients. The company was founded in 1960 and is based in Seoul, South Korea.


Keywords: Medicine Pharmaceutical Pain Medication Diabetes Inflammation Stem Cell Parkinson's Disease Rheumatoid Arthritis Arthritis Asthma Hepatitis Cough Obesity Osteoporosis Osteoarthritis Respiratory Diseases Liver Disease Anemia Acne Diarrhea Dermatitis Constipation Fever Eczema Multivitamin Rhinitis Onychomycosis Candidiasis Health Functional Food Neuralgia Athlete's Foot Physical Fatigue

Home Page: www.bukwang.co.kr

7, Sangdo-ro
Seoul, 06955
South Korea
Phone: 82 2 828 8114


Officers

Name Title
Sung-Gu Lee Chief Exec. Officer, Pres and Director
Ms. Yoo Hui-Won Chief Exec. Officer and Representative Director
Tae-Hyun Kim VP and Director
Won-Tae Park Managing Director and Director
Il-Tae Kim Managing Director
Young-Choon Lee Managing Director
Geum-Seo Gu Managing Director
Jong-Moon Kim Managing Director
Mr. Sang-Hoon Kim Sr. Managing Director, Head of Planning Adjustment Department and Representative Director
Hee-Sang Lee Managing Director

Exchange: KO

Country: KR : Korea (Republic of)

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.451
Price-to-Sales TTM: 3.5502
IPO Date:
Fiscal Year End: December
Full Time Employees: 568
Back to stocks